"Apple Watch Health Features Under Fire: CEO Criticizes Blood Oxygen Sensor and Import Bans"

Masimo CEO Joe Kiani confirmed that there have been no discussions with Apple about a possible settlement regarding the legal dispute over the Apple Watch blood oxygen sensor, which allegedly uses Masimo-patented technology. Kiani criticized the sensor's reliability and lack of FDA clearance, stating that consumers are "better off without it." The U.S. International Trade Commission ruled in favor of Masimo, leading to an import ban on Apple Watch models with a functional blood oxygen sensor in the U.S. As a result, Apple is selling modified models without the sensor enabled, but may update them in the future pending a settlement or ruling overturn.